- Home
- SCWO vs ECOR Comparison
SCWO vs ECOR Comparison
Compare SCWO & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCWO
- ECOR
- Stock Information
- Founded
- SCWO 2021
- ECOR 2005
- Country
- SCWO United States
- ECOR United States
- Employees
- SCWO N/A
- ECOR N/A
- Industry
- SCWO Environmental Services
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SCWO Utilities
- ECOR Health Care
- Exchange
- SCWO Nasdaq
- ECOR Nasdaq
- Market Cap
- SCWO 35.5M
- ECOR 39.7M
- IPO Year
- SCWO N/A
- ECOR 2018
- Fundamental
- Price
- SCWO $0.24
- ECOR $5.21
- Analyst Decision
- SCWO
- ECOR Strong Buy
- Analyst Count
- SCWO 0
- ECOR 2
- Target Price
- SCWO N/A
- ECOR $25.50
- AVG Volume (30 Days)
- SCWO 1.2M
- ECOR 120.6K
- Earning Date
- SCWO 08-12-2025
- ECOR 08-06-2025
- Dividend Yield
- SCWO N/A
- ECOR N/A
- EPS Growth
- SCWO N/A
- ECOR N/A
- EPS
- SCWO N/A
- ECOR N/A
- Revenue
- SCWO $1,231,413.00
- ECOR $27,700,000.00
- Revenue This Year
- SCWO $5,945.19
- ECOR $23.21
- Revenue Next Year
- SCWO $106.82
- ECOR $44.10
- P/E Ratio
- SCWO N/A
- ECOR N/A
- Revenue Growth
- SCWO 403.17
- ECOR 30.16
- 52 Week Low
- SCWO $0.16
- ECOR $4.16
- 52 Week High
- SCWO $1.99
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- SCWO 45.94
- ECOR 42.32
- Support Level
- SCWO $0.22
- ECOR $4.16
- Resistance Level
- SCWO $0.27
- ECOR $5.58
- Average True Range (ATR)
- SCWO 0.03
- ECOR 0.54
- MACD
- SCWO 0.00
- ECOR -0.10
- Stochastic Oscillator
- SCWO 68.18
- ECOR 32.41
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The company's business activities include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.